Pneumocystis Pneumonia: Still a serious disease in children

J Mother Child. 2021 Jan 29;23(3):159-162. doi: 10.34763/devperiodmed.20192303.159162.

Abstract

Pneumocystis carinii pneumonia is a common opportunistic respiratory infection among children with human immunodeficiency virus and a weakened immune system. The primary infection in immunocompetent patients may be asymptomatic, whereas fever, shortness of breath, night sweats, nonproductive (dry) cough, pneumonia, progressive respiratory distress and apnea are cardinal symptoms of full-blown pneumocystis pneumonia. The diagnosis can be confirmed by histochemical staining of biological specimens or, recently, by polymerase chain reaction. International recommendations indicate that the drug of choice is the intravenously administered trimethoprim-sulfamethoxazole combination. Early diagnosis and appropriate treatment reduce the mortality of the disease. This article briefly highlights the epidemiology of Pneumocystis pneumonia, its diagnosis and therapeutic options in the pediatric population.

Keywords: Pneumocystis pneumonia; children; symptoms; treatment.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / prevention & control
  • Child
  • Humans
  • Pneumonia, Pneumocystis / diagnosis*
  • Pneumonia, Pneumocystis / drug therapy*
  • Pneumonia, Pneumocystis / etiology
  • Pneumonia, Pneumocystis / prevention & control
  • Risk Factors
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

  • Trimethoprim, Sulfamethoxazole Drug Combination